Skip to content

NEO

NeoGenomics, Inc.

Stock

$18.47+0.69 (+3.88%)Close Oct 2, 2026

Free cash flow, 2025
−$22M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$22M—
2024−$34M—
2023−$31M—
2022−$97M—
2021−$91M—
2020−$28M—
2019$3.3M−89.0%
2018$30M+601.1%
2017$4.3M−68.8%
2016$14M+233.7%
2015$4.2M−26.4%
2014$5.7M+2,528.7%
2013$216K—
2012−$3.1M—
2011−$828K—
2010−$3.0M—